Published :
Tables : 63
Figures : 46
Category : Healthcare
No. of Pages : 225
Report Code : HC-U3276
Companion Animal Specialty Drugs Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027. Increased developments in advanced biologics technologies like recombinant DNA vaccines is the primary factor responsible for the growth of the market. A companion animal is primarily referred to a dog or a cat or those who are domesticated near the household of the person caring for them. Rising awareness regarding animal healthcare in developed as well as developing countries along with the increased demand for compounded drugs shall boost the companion animal specialty drugs market growth. DNA vaccines used for dogs are predicted to increase the demand for veterinary vaccine specialities. The recombinant vaccines offer novel protection to petting animals. Such factors are responsible for the growth of the market. As per a survey performed in 2012, over 40% of children aged five years were reported to look for their pets when they felt sad or happy. Furthermore, as per the survey conducted by the Animal Pet Products Association in 2012, over 60% of householders in the United States own single or multiple companion animals. Advantages of owing a companion animal, increased urbanization and rising number of nuclear families are some of the reasons responsible for the proliferation of the market. Market Segmentation: By Product Type • Vaccines • Anti-Inflammatory Drugs • Animal Feed Additives • Antibiotics • Skin Care Products • Parasiticides • Others By Distribution Channel • Veterinary Clinics • Hospital Pharmacies • Drug Stores By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is classified into distribution channel, product type and region. The product type segment is fragmented into vaccines, anti-inflammatory drugs, animal feed additives, antibiotics, skin care products, skin care products, parasiticides and others. The distribution channel segment is categorised into veterinary clinics, hospital pharmacies and drug stores. The veterinary clinics segment is predicted to account the largest companion animal specialty drugs market share during the forecast period. Regional Analysis: The North America region is estimated to lead the market during the forecasted timeframe, and this can be credited to the increased number of companion animal ownerships in households of the United States. Furthermore, with people living a stressful lifestyle in developed nations like the US, owing a pet provides the necessary emotional support which has bolstered the market growth in the region. Competitive Landscape: Some of the prominent market players are Zoetis Inc., Merck & Co., Inc., Bayer AG, Elanco (a division of Eli Lilly & Company), Boehringer Ingelheim Animal Health Gmbh, Ceva Sante Animale S.A., Aratana Therapeutics, Merial, The J.M Smucker Company, Mars, Beaphar. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global companion animal specialty drugs market by product type, by distribution channel and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased developments in advanced biologics technologies like recombinant DNA vaccines is the primary factor responsible for the growth of the market. A companion animal is primarily referred to a dog or a cat or those who are domesticated near the household of the person caring for them. Rising awareness regarding animal healthcare in developed as well as developing countries along with the increased demand for compounded drugs shall boost the companion animal specialty drugs market growth. DNA vaccines used for dogs are predicted to increase the demand for veterinary vaccine specialities. The recombinant vaccines offer novel protection to petting animals. Such factors are responsible for the growth of the market. As per a survey performed in 2012, over 40% of children aged five years were reported to look for their pets when they felt sad or happy. Furthermore, as per the survey conducted by the Animal Pet Products Association in 2012, over 60% of householders in the United States own single or multiple companion animals. Advantages of owing a companion animal, increased urbanization and rising number of nuclear families are some of the reasons responsible for the proliferation of the market.
Market Segmentation:
By Product Type • Vaccines • Anti-Inflammatory Drugs • Animal Feed Additives • Antibiotics • Skin Care Products • Parasiticides • Others By Distribution Channel • Veterinary Clinics • Hospital Pharmacies • Drug Stores By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is classified into distribution channel, product type and region. The product type segment is fragmented into vaccines, anti-inflammatory drugs, animal feed additives, antibiotics, skin care products, skin care products, parasiticides and others. The distribution channel segment is categorised into veterinary clinics, hospital pharmacies and drug stores. The veterinary clinics segment is predicted to account the largest companion animal specialty drugs market share during the forecast period.
Regional Analysis:
The North America region is estimated to lead the market during the forecasted timeframe, and this can be credited to the increased number of companion animal ownerships in households of the United States. Furthermore, with people living a stressful lifestyle in developed nations like the US, owing a pet provides the necessary emotional support which has bolstered the market growth in the region.
Competitive Landscape:
Some of the prominent market players are Zoetis Inc., Merck & Co., Inc., Bayer AG, Elanco (a division of Eli Lilly & Company), Boehringer Ingelheim Animal Health Gmbh, Ceva Sante Animale S.A., Aratana Therapeutics, Merial, The J.M Smucker Company, Mars, Beaphar.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global companion animal specialty drugs market by product type, by distribution channel and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Companion Animal Specialty Drugs Market, By Product Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Vaccines 7.2 Anti-Inflammatory Drugs 7.3 Animal Feed Additives 7.4 Antibiotics 7.5 Skin Care Products 7.6 Parasiticides 7.7 Others 8. Companion Animal Specialty Drugs Market, By Distribution Channel Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Veterinary Clinics 8.2 Hospital Pharmacies 8.3 Drug Stores 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Zoetis Inc. 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Merck & Co., Inc. 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 Bayer AG 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Elanco 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Boehringer Ingelheim Animal Health Gmbh 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Ceva Sante Animale S.A. 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 Aratana Therapeutics 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Merial 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 The J.M Smucker Company 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Beaphar 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15 Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18. Relevant Case Studies and Latest News Updates 19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics